Inomagen Therapeutics, Inc. — Form D
Inomagen Therapeutics, Inc. of CHICAGO, IL, a company, filed a Form D exempt-offering notice with the SEC on 2024-04-12. The offering totals $6.6M, of which $200K was reported sold. Industry: Biotechnology.
Offering
- Filed: 2024-04-12
- Form: D
- Accession: 0001626370-24-000003
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $6.6M
- Amount sold: $200K
- Remaining: $6.4M
- Investors: 4
- Date of first sale: 2024-03-29
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-510456
Issuer
- Name: Inomagen Therapeutics, Inc.
- CIK: 0001626370
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2014
- Address: 1375 W Fulton Street, CHICAGO, IL, 60607
- Phone: 312 805 8701
Officers, directors & promoters (4)
| Name | Role | Location |
|---|
| Rishi Arora | Director | Chicago, IL |
| Rishi Arora | Executive Officer | Chicago, IL |
| Marc R Penn | Director | Chicago, IL |
| James R Vogler | Director | Chicago, IL |
Other filings by this issuer (2)
More